Stem cells play important roles in normal physiology, and their deregulated functions are involved in diseases such as cancer. The normal stem cells have the potential to differentiate into different cell types during development [1] . In adults, somatic stem cells are a valuable source for tissuespecific cell types to replace aged or damaged cells [2] . Cancer stem cells are cells within a tumor which possess some stem cell properties [3] . A cancer stem cell removed from its original tumor and seeded in a new organ or tissue type can form a brand new tumor in the new location, a process known as metastasis [4] . Stem cells can be regulated at both transcriptional and genomic levels. Transcription factors and their coactivators or corepressors are very important both in normal stem cell function and in cancer stem cell maintenance [5] [6] [7] . Genetic mutations resulted from replication errors or defective repair mechanisms affect genome stability and stem cell functions [8, 9] . Therapeutic targeting of stem cell regulation has the potential to alleviate disease condition and to find a cure in the fight against cancer.
This special issue contains review articles that offer new insight into the current status of the research areas. In one of the reviews, M. Wang et al. presented the common types of molecular mutations that can occur as a single mutation or as combinations of two or three mutations in cytogenetically normal acute myeloid leukemia (CN-AML). They analyzed available AML databases using bioinformatics tools at their disposal and found that mutations in stem cell regulatory factors such as FLT3, TET2, DNMT3A, and IDH1 often have an unfavorable clinical outcome and may predict relapse of leukemia in CN-AML patients. In another review, S. Zhang et al. This special issue also includes original research articles of various aspects related to the topic. L. Guo et al. observed the effect of resveratrol treatment on human umbilical cord mesenchymal stem cells (hUC-MSCs). They found that resveratrol at relatively high concentrations (15.0 and 30.0 mg/ L) stimulated the hUC-MSC differentiation into neuronlike cells as evidenced by the increased expression of nestin and neuron-specific enolase (NSE) at protein and mRNA levels four hours after treatment. On the other hand, expression of glial fibrillary acidic protein (GFAP) showed no change after resveratrol treatment, indicating that differentiation of hUC-MSCs into glial cells did not occur after resveratrol stimulation. The discovery may be of therapeutic importance. One other research article by C. Yang et al. investigated the maintenance of stemness in triple-negative breast cancer (TNBC) which is enriched in cancer stem cells. They analyzed available TCGA datasets and several smallersize datasets of breast cancer and demonstrated that cadherin family members CDH2, 4, 6, and 17 were upregulated when E-cadherin (CDH1) was lost or downregulated. Changes in the expression of CDH2/4/6/17 were associated with increased expression of several important stem cell-related transcription factors including FOXM1, MCM2, WWTR1, and Sox9. Further analysis by connectivity map search indicated that small compounds may be of therapeutic use in targeting TNBC when expression of CDHs is altered. In another research article, A. Po et al. studied the maintenance of stemness in normal cerebellar stem cells (CSC). They showed that silencing of intragenic miR-326 and its host gene β-arrestin1 by epigenetic modification, specifically by CpG islands methylation, of β-arrestin1 promoter contributes to the maintenance of stem cell properties of CSCs. They further showed that the use of demethylating agents triggered differentiation program and promoted cell growth, but inhibited cell proliferation.
In summary, enormous progress has been made in genomic and transcriptional control of stem cells in development and cancer. Reviews and original research articles presented in this special issue bring to light recent development and future challenges ahead.
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